story • 1 min read MyMD Pharmaceuticals Receives Decision To Grant European Patent Titled ‘Genetically Modified Cannabis Sativa Plants And Modified Cannabinoid Compounds For Treatment Of Substance Addiction And Other Disorders’ https://twitter.com/PatentGrants/status/1531687979588038656 igniteit May 31, 2022 • 5:25 pm Share:
